Alivcor

US-based innovator in mobile technology for heart health AliveCor has secured CE Mark clearance for its automated analysis process (algorithm) to detect atrial fibrillation (AF), the most common cause of a stroke.

The latest version of the AliveECG app provides patients in the UK and Ireland with real-time AF detection in electrocardiogram (ECG) recordings using the AliveCor Heart Monitor.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The Heart Monitor has been developed to record, store and transfer single-channel ECG rhythms, while it will also display ECG rhythms and detects the presence of atrial fibrillation.

Each recorded ECG will be analysed by the new AF Detector, which will automatically notify the user if AF is detected in that ECG.

St Helier Hospital consultant cardiologist Richard Bogle said: "The new AF Detector, along with the tracking of medications and lifestyle factors, will make it easier for me to identify and manage serious heart arrhythmias in my patients.

"My patients will significantly benefit from being able to find out if they are having an AF episode and together it will allow us to determine which medications, habits and activities may be impacting their heart.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData
"The new AF Detector will make it easier for me to identify and manage serious heart arrhythmias in my patients."

"With a more complete view of what is happening with my patients, even between appointments, we can make better decisions."

The new detector marks a major step in the advancement of mobile health, enabling patients to instantly know if AF is present in their ECG, and immediately take action as recommended by their physician.

AliveCor president and CEO Euan Thomson said: "The UK and Ireland make up more than 20% of our customers and we are excited to now be able to share the AF Detector with them as a powerful tool to help manage their heart conditions.

"The AF Detector, and our continued efforts to support the local community with screening for AF, reconfirm our goal of providing patients and caregivers with clinical-quality, mobile health technology and analysis that can improve heart health."

The new AliveECG app also includes features that help patients and physicians manage existing conditions with intelligent, personalized and new features.


Image: The latest version of the AliveECG app will help patients to detect AF in ECG recordings using the AliveCor Heart Monitor. Photo: courtesy of PRNewswire/ AliveCor, Inc.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact